Insider Transactions in Q1 2022 at Spero Therapeutics, Inc. (SPRO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2022
|
Aquilo Capital Management, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+0.47%
|
$400,000
$8.79 P/Share
|
|
Mar 14
2022
|
Aquilo Capital Management, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
23,708
+0.23%
|
$165,956
$7.63 P/Share
|
|
Feb 28
2022
|
Aquilo Capital Management, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
44,833
+0.43%
|
$403,497
$9.53 P/Share
|
|
Feb 18
2022
|
Aquilo Capital Management, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
14,828
+0.29%
|
$133,452
$9.24 P/Share
|
|
Feb 01
2022
|
Tamara L Joseph Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,014
+37.98%
|
-
|
|
Feb 01
2022
|
Timothy Keutzer Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,014
+37.05%
|
-
|
|
Feb 01
2022
|
Ankit Mahadevia |
BUY
Grant, award, or other acquisition
|
Direct |
134,168
+32.54%
|
-
|
|
Feb 01
2022
|
Cristina Larkin Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,014
+37.42%
|
-
|
|
Feb 01
2022
|
Sath Shukla CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
38,014
+37.98%
|
-
|
|
Feb 01
2022
|
David A. Melnick Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,014
+37.98%
|
-
|
|
Jan 31
2022
|
Aquilo Capital Management, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
125,000
+2.37%
|
$1,375,000
$11.59 P/Share
|
|
Jan 24
2022
|
Aquilo Capital Management, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,599
+0.03%
|
$15,990
$10.89 P/Share
|
|
Jan 18
2022
|
Aquilo Capital Management, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
48,488
+0.96%
|
$581,856
$12.41 P/Share
|
|
Jan 10
2022
|
Aquilo Capital Management, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,867
+0.18%
|
$106,404
$12.93 P/Share
|